Download Product Catalogue

Product Detail

KALSTIN-1

Kalstin-1

Colistimethate 1 MIU Injection

Therapy of severe multidrug-resistant (MDR) Gram-negative bacterial infections.

Therapy of severe multidrug-resistant (MDR) Gram-negative bacterial infections. Active against Pseudomonas aeruginosa infections, Acinetobacter baumannii infections, Klebsiella pneumoniae infections. Applied in septicemia, pneumonia, urinary tract infection, intra-abdominal infection, and meningitis (in case of failure of other antibiotics).

MRP: ₹1170/-
Send Enquiry

100%

Certified Products

Secure

pAYMENTS

24/7

Customer Support

100%

Certified Products

Secure

PAYMENTS

24/7

Customer Support

About The Product

Uses

Therapy of severe multidrug-resistant (MDR) Gram-negative bacterial infections. Active against Pseudomonas aeruginosa infections, Acinetobacter baumannii infections, Klebsiella pneumoniae infections. Applied in septicemia, pneumonia, urinary tract infection, intra-abdominal infection, and meningitis (in case of failure of other antibiotics).

Side Effects

  • Nephrotoxicity (damage to the kidneys) Neurotoxicity (dizziness, tingling, muscle weakness, confusion, seizures) Allergies (rash, itching, swelling) Nausea, vomiting, diarrhea Local pain or soreness at injection site

Uses

Therapy of severe multidrug-resistant (MDR) Gram-negative bacterial infections. Active against Pseudomonas aeruginosa infections, Acinetobacter baumannii infections, Klebsiella pneumoniae infections. Applied in septicemia, pneumonia, urinary tract infection, intra-abdominal infection, and meningitis (in case of failure of other antibiotics).

Side Effects

  • Nephrotoxicity (damage to the kidneys) Neurotoxicity (dizziness, tingling, muscle weakness, confusion, seizures) Allergies (rash, itching, swelling) Nausea, vomiting, diarrhea Local pain or soreness at injection site

Indications

  • Hospital-acquired pneumonia (HAP/VAP) MDR Gram-negative bacteremia & septicemia Complex UTIs (cUTI) Intra-abdominal infections Infections of CNS (such as meningitis) by susceptible bacteria

FAQ

Q1: What is KALSTIN-1 (Colistimethate 1 MIU)?
It is applied in treatment of life-threatening multidrug-resistant Gram-negative bacterial infections, particularly where other antibiotics do not work.

Q2: Is Colistimethate kidney safe?
Some patients may experience kidney damage (nephrotoxicity) with it. Monitoring of kidney functioning should be conducted regularly in the course of treatment.

Q3: What is the administration of Colistimethate?
It is given intravenously (IV) or intramuscularly (IM) under medical care in the hospital.

Q4: Is it applicable in children?
Yes, but only with close pediatric specialist supervision, and dose adjustments.

Q5: Is it possible to take it at home?
No, it should be administered only in hospital/clinical settings with supervision because of the risk of severe side effects.

Indications

  • Hospital-acquired pneumonia (HAP/VAP) MDR Gram-negative bacteremia & septicemia Complex UTIs (cUTI) Intra-abdominal infections Infections of CNS (such as meningitis) by susceptible bacteria

FAQ

Q1: What is KALSTIN-1 (Colistimethate 1 MIU)?
It is applied in treatment of life-threatening multidrug-resistant Gram-negative bacterial infections, particularly where other antibiotics do not work.

Q2: Is Colistimethate kidney safe?
Some patients may experience kidney damage (nephrotoxicity) with it. Monitoring of kidney functioning should be conducted regularly in the course of treatment.

Q3: What is the administration of Colistimethate?
It is given intravenously (IV) or intramuscularly (IM) under medical care in the hospital.

Q4: Is it applicable in children?
Yes, but only with close pediatric specialist supervision, and dose adjustments.

Q5: Is it possible to take it at home?
No, it should be administered only in hospital/clinical settings with supervision because of the risk of severe side effects.

Request a Callback